Analystreport

Genocea Biosciences Inc (NASDAQ: GNCA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.

Genocea Biosciences, Inc.  (GNCA) 
Last genocea biosciences, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.genocea.com